Private Market View

Neuralink

Fremont, CA · Founded 2016 · Privately Held (backing)

PA Mark · $/share
$156
Sep 2026
Implied valuation
$29.8B
Total raised
$1.3B
Last round
Secondary Transaction - Private
Feb 2026

Key facts

as of Sep 2026
  • Neuralink is valued at approximately $29.8B (~$156/share) as of Sep 2026, per Private Market View’s composite mark.
  • It has raised $1.3B across 7 recorded rounds; the latest was Later Stage VC ($650.0M) in Jun 2025.
  • Notable investors include Sequoia Capital, Lightspeed Venture Partners, GV, Founders Fund, Calm Ventures — 82 tracked in total.
  • 2 institutional filers report fund marks on Neuralink across 9 filings.
  • Private Market View tracks 36 recorded secondary trades in Neuralink shares.
  • 1 investment vehicle was formed to buy Neuralink shares in the last 12 months, per SEC Form D filings.
  • Neuralink has filed 6 Form Ds with the SEC since 2017, most recently Jun 2025 ($649.0M sold to 49 investors).
  • Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence
~$156per share
implies $29.8B valuation · as of Sep 2026 · the exact daily mark is a member feature
Composed from 6 inputs:3rd-party trades 69%N-PORT marks 31%
See the platform prints behind this mark →
Free account
See the evidence behind this price
  • ·Post-money valuations for all 7 rounds
  • ·The complete investor list — 82 names
  • ·Watchlist + deal alerts for Neuralink
Create free account
No card required

Recorded secondary trades

36 on record · Aug 2022 – May 2026

36 trades between Aug 2022 and May 2026. Exact dates, prices and structures are available to Pro members.

Aug 2022peak 5 prints / monthMay 2026
Counts and months are public. The prints are the product.Unlock 36 trade prints

Institutional fund marks

2 filers · latest Jun 2026

2 SEC-registered funds reported 9 fair-value marks on Neuralink between Jun 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.

Unlock 9 fund marks

Funding rounds

7 rounds
Feb 2026Secondary Transaction - Private—▮
Jun 2025Series E$650.0M▮
Nov 2023Series D$323.2M▮
Jul 2021Series C$205.9M▮
Jun 2019Series B$51.0M▮
Full funding history →

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Neuralink shares. Most recent filing Jun 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →
Companies with the most vehicle activity →

Leadership

About Neuralink

Developer of an implantable brain-machine interface designed to help people with paralysis. The company's interface treats and diagnoses neurological conditions in humans and, conceivably, augments human cognitive powers, enabling doctors to treat serious brain diseases in the short term.

Sector
Biotechnology
HQ
Fremont, CA, United States
Founded
2016
Employees
492
Ownership
Privately Held (backing)